Outset Medical is prominently recognized for its innovative Tablo Hemodialysis System, which revolutionized the dialysis ...

Outset Medical Inc is a medical technology company. It has developed a machine, Tablo, which reduces the cost and complexity of dialysis. Tablo provides Renal Replacement Therapy in Hospitals, Chronic ...

Outset Medical (Nasdaq: OM) shares got a boost today on fourth-quarter results that topped the consensus forecast on Wall ...

Q4 2024 Earnings Call Transcript February 19, 2025 Outset Medical, Inc. beats earnings expectations. Reported EPS is $-0.37, ...

Outset provided 2025 revenue guidance of $115 million to $125 million, and non-GAAP gross margin guidance in the high-30% range. Additionally, the company expects to use less than $50 million of cash ...

Outset Medical (Nasdaq: OM) announced today that the FDA says it addressed all issues cited in a 2023 warning letter.

We are pleased to achieve this important milestone and remain vigilant as we work to continuously improve everything we do on behalf of the patients and providers we serve.” About Outset Medical, Inc.

About Outset Medical, Inc. Outset is a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis. The Tablo® Hemodialysis System ...

SAN JOSE - Outset Medical (TASE:PMCN), Inc. (NASDAQ:OM), a medical technology company focused on innovating dialysis treatment, has resolved all concerns raised in a Warning Letter from the U.S ...

About Outset Medical, Inc. Outset is a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis. The Tablo® Hemodialysis System ...